Complementary Oncology Report
Complementary Oncology Report is a source for like-minded practitioners, with a TCM and Complementary Health background, to engage in evidence-based integrative oncology. In our studies in Australia, the US and China, and our meetings with orthodox oncologists, we have found both an increasing acceptance of the idea of integration and an increasing amount of evidence to support these integrative approaches to oncology. This is due to an increasing number of studies on the efficacy of botanical, non-standard interventions and a real need to provide the best treatment for cancer patients.
Latest works
-
Evidence-based Chinese medicine for cancer therapy
V. Badireenath Konkimalla, Thomas Efferth. Journal of Ethnopharmacology. Volume 116, Issue 2, 5 March 2008, Pages 207–210 http://dx.doi.org/10.1016/j.jep.2007.12.009 Abstract In contrast to western medicine (WM), traditional [...]
-
Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by silibinin: involvement of protein kinase C
The effect of silibinin, an active component of Silybum marianum, on cellular differentiation was investigated in the human promyelocytic leukemia HL-60 cell culture system. Treatment of [...]
-
Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin
Artemisinin, a sesquiterpene lactone endoperoxide that exists in several medicinal plants, is a well-known anti-malarial agent. In this report, we investigated the effect of artemisinin on [...]
-
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
Iron(II) heme-mediated activation of the peroxide bond of artemisinins is thought to generate the radical oxygen species responsible for their antimalarial activity. We analyzed the role [...]
-
SILIBININ
Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3 [...]
-
Astragalus
Astragalus membranaceous (huang qi) Antineoplastic properties/amelioration of chemotherapy side effects: There is in vitro evidence that astragalus can potentiate the efficacy and reduce the adverse effects [...]
-
Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
Silibinin inhibits mouse lung tumorigenesis in part by targeting tumor microenvironment. Tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) can be pro- or anti-tumorigenic, but in lung [...]
Daniel Weber International
ICOP
